Dudediligence.

Tectonic Therapeutic, Inc

TECXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,270,284

9 notices · 40,133 sh

Oct 2025 to Oct 2026

Reported ·

$629,562

7 sales · 2 buys · $182,410 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 7 reported sales carry the 10b5-1 box. Together they are 0.11% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-30: PETER MCNAMARA, Form 1442026-08-27: TERRANCE MCGUIRE, Form 1442026-08-21: TERRANCE MCGUIRE, Form 1442026-08-12: PETER MCNAMARA, Form 1442026-06-30: PETER MCNAMARA, Form 1442026-03-06: PETER MCNAMARA, Form 1442026-03-06: MARCELLA RUDDY, Form 1442026-03-04: PETER MCNAMARA, Form 1442026-03-03: PETER MCNAMARA, Form 1442026-02-10: Lochner Daniel, bought2026-02-11: REICIN ALISE, bought2026-03-03: McNamara Peter, sold2026-03-06: McNamara Peter, sold2026-03-06: Ruddy Marcella K., sold2026-04-01: Ruddy Marcella K., sold2026-05-04: Ruddy Marcella K., sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-30PETER MCNAMARA, Chief Scientific Officer$11,507
493 shplan 2025-11-14Form 4s on file end Jun 23144 ↗
2026-08-27TERRANCE MCGUIRE, Former Director$276,718
7,513 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-21TERRANCE MCGUIRE, Former Director$383,671
10,200 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-12PETER MCNAMARA, Chief Scientific Officer$4,111
129 shplan 2025-11-14Form 4s on file end Jun 23144 ↗
2026-06-30PETER MCNAMARA, Chief Scientific Officer$5,691
172 shplan 2025-11-14Form 4s on file end Jun 23144 ↗
2026-03-06PETER MCNAMARA, Chief Scientific Officer$174,397
6,262 shplan 2025-11-14144 ↗
Form 4, 2026-03-09: sold 6,262 at $30.17 Form 4 ↗
2026-03-06MARCELLA RUDDY, Chief Medical Officer$336,010
12,065 shplan 2025-04-08144 ↗
Form 4, 2026-03-09: sold 10,000 at $30.00 Form 4 ↗
2026-03-04PETER MCNAMARA, Chief Scientific Officer$40,252
1,650 shplan 2025-11-14no Form 4 on file144 ↗
2026-03-03PETER MCNAMARA, Chief Scientific Officer$37,927
1,649 shplan 2025-11-14144 ↗
Form 4, 2026-03-05: sold 3,299 at $23.53 Form 4 ↗